Ms. Ohrmund is a Senior Associate with more than 15 years of experience in small molecule research, diagnostic assay development, and logistics support in the life sciences and trade show industries. At LBG, she serves as a project manager for both private and government-funded product development projects across a variety of product types and indications.
Ms. Ohrmund was responsible for the diagnostic development, validation, and transfer to tech ops of the Anser® IFX and Anser® ADA diagnostic assays. In support of this project, she managed the development of proof-of-concept assays, preparation of protein and antibody conjugations, preparation of IP for patents, training of technicians, creation of SOPs, and preparation of validation reports. She also collaborated with academic leaders in the field to screen samples, analyze data, and prepare results for publication using the Anser® platforms.
Ms. Ohrmund worked in small molecule research and development for five years. During that time, she served as the IACUC chairperson and performed a wide variety of in vitro and in vivo assays. She collaborated with Vanderbilt to screen activity of novel compounds using IHC, trained peers on proper IHC and ICC techniques, and implemented a mouse model of multiple sclerosis (EAE).
Ms. Ohrmund holds a B.S. in Biochemistry and Cell Biology from University of California San Diego. In addition, she received a Project Management Professional certification (PMP®) from the Project Management Institute (PMI).
